Show items per page
Elements: 14
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients Boursier, J; Ducancelle, A; Vergniol, J; Veillon, P; ... De Lédinghen, V 2015
add to browser selection
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome Fattovich, Giovanna; Baroni, Gianluca Svegliati; Pasino, Michela; Pierantonelli, Irene; ... Negro, Francesco 2012
add to browser selection
The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients Baur, Katharina; Mertens, Joachim C; Schmitt, Johannes; Iwata, Rika; ... Rubbia-Brandt, Laura 2012
add to browser selection
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study Bezemer, Geert; Van Gool, Arthur R; Verheij-Hart, Elke; Hansen, Bettina E; ... de Knegt, Robert J 2012
add to browser selection
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. Lange, Christian M; Bibert, Stéphanie; Kutalik, Zoltan; Burgisser, Philippe; ... Moradpour, Darius 2012
add to browser selection
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy Lange, Christian M; Kutalik, Zoltan; Morikawa, Kenichi; Bibert, Stéphanie; ... Bochud, Pierre-Yves 2012
add to browser selection
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients Fattovich, Giovanna; Covolo, Loredana; Pasino, Michela; Perini, Eleonora; ... Donato, Francesco 2011
add to browser selection
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. Bochud, Pierre-Yves; Bibert, Stéphanie; Negro, Francesco; Haagmans, B; ... Lagging, M 2011
add to browser selection
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study Suppiah, Vijayaprakash; Gaudieri, Silvana; Armstrong, Nicola J; O'Connor, Kate S; ... Booth, David R 2011
add to browser selection
Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3 Poustchi, Hossein; Negro, Francesco; Hui, Jason; Cua, Ian Homer Y.; ... George, Jacob 2008
add to browser selection
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients Bruggmann, P.; Falcato, L.; Dober, S.; Helbling, B.; ... Meili, D. 2008
add to browser selection
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy Pugnale, Paolo; Herrmann, Eva; Neumann, Avidan U.; Pawlotsky, Jean-Michel; ... Negro, Francesco 2008
add to browser selection
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study Zinkernagel, A. S.; von Wyl, Viktor; Ledergerber, Bruno; Rickenbach, Martin; ... Weber, Rainer 2006
add to browser selection
Immunological and virological effects of ribavirin in hepatitis C after liver transplantation Quadri Defilippis, Rafael; Giostra, Emiliano; Roskams, Tania; Pawlotsky, Jean-Michel; ... Negro, Francesco 2002